Dose Escalation and Dose Expansion Study of CPO-100 in Patients With Advanced Solid Tumors
Conjupro Biotherapeutics, Inc.
Conjupro Biotherapeutics, Inc.
The First Affiliated Hospital of Xiamen University
Centre Oscar Lambret
Hoffmann-La Roche
Luzerner Kantonsspital
Pfizer
Ocellaris Pharma, Inc.
Shasqi, Inc.
Pfizer
Incyte Corporation
Icahn School of Medicine at Mount Sinai
NuCana plc
Numab Therapeutics AG
Poseida Therapeutics, Inc.
Aminex Therapeutics, Inc.
Atara Biotherapeutics
Astellas Pharma Inc
GlaxoSmithKline
NKGen Biotech, Inc.
SQZ Biotechnologies
CytomX Therapeutics
Hoffmann-La Roche
Oncorus, Inc.
Seagen Inc.
Advaxis, Inc.
Amgen
Fox Chase Cancer Center
Genocea Biosciences, Inc.
Inovio Pharmaceuticals
Inovio Pharmaceuticals
PCI Biotech AS
University of California, Davis
Merck Sharp & Dohme LLC
AbbVie
Effector Therapeutics
Daiichi Sankyo
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Case Comprehensive Cancer Center
Dartmouth-Hitchcock Medical Center
University of Arizona
CureOne
Novartis
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Celldex Therapeutics
National Institutes of Health Clinical Center (CC)
AbbVie
Anandasabapathy, Sharmila, M.D.